ImmunityBio, Inc. — Director's Dealing 2020

Dec 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2020-12-10

Reporting Person: Thomas John C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-10	Common Stock	S	42592	$10.8265	Disposed	207477	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13886	Indirect

Footnotes

F1: The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 10, 2020.

F2: Represents the weighted average share price of an aggregate total of 42,592 shares sold in the price range of $10.17 to $11.14 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Reported shares held by the John C Thomas Jr. Trustee Susan T Thomas U/W DTD 5/10/96.